• West Asia impact: Geopolitical tensions caused ₹7 to 8 crore worth of cancellations in Q4, with an additional ₹7 to 8 crore hit expected in Q1, though domestic MICE demand and higher room rates helped offset the shortfall.
• Growth and margins: The company is targeting mid-teen revenue and EBITDA growth for FY27, aiming to maintain average portfolio EBITDA margins near 40% over the next two years after reaching 39.7% in Q4.
• Capex and funding: A planned ₹3,400 crore capital expenditure will add nine new hotels to the existing nine-hotel portfolio, funded primarily by ₹2,000 to 2,200 crore in debt, alongside internal accruals and IPO proceeds.
• Inorganic acquisition strategy: Management has allocated ₹90 to 100 crore from IPO proceeds to evaluate and acquire at least one ready-to-operate hotel asset in the coming year.